SYDNEY, Aug. 12, 2024 /PRNewswire/ — ESY SUNHOME, a premier innovator in renewable energy solutions, has achieved a significant milestone by completing the first successful installation and testing of IEEE 2030.5 cloud-grid integration in South Australia. This groundbreaking advancement…
Month: August 2024
SYDNEY, Australien, 12. August 2024 /PRNewswire/ — ESY SUNHOME, ein führender Innovator im Bereich erneuerbare Energielösungen, hat einen bedeutenden Meilenstein erreicht, indem es die erste erfolgreiche Installation und Prüfung der Cloud-Netzintegration auf Basis von IEEE 2030.5 in…
SYDNEY, Australie, 12 août 2024 /PRNewswire/ — ESY SUNHOME, innovateur de premier plan dans les solutions d’énergie renouvelable, a franchi une étape majeure en réalisant avec succès la première installation et les tests de l’intégration cloud-réseau basée sur la norme IEEE 2030.5 en…
SÍDNEY, Australia, 12 de agosto de 2024 /PRNewswire/ — ESY SUNHOME, un destacado innovador en soluciones de energía renovable, ha alcanzado un hito significativo al completar con éxito la primera instalación y prueba de integración de red en la nube basada en IEEE 2030.5 en Australia del…
SYDNEY, Australië, 12 augustus 2024 /PRNewswire/ — ESY SUNHOME, een toonaangevende innovator op het gebied van hernieuwbare energieoplossingen, heeft een belangrijke mijlpaal bereikt door de eerste succesvolle installatie en test van cloud-netwerkintegratie op basis van IEEE 2030.5 in…
A Leading Producer of Monoclonal Antibodies LEBANON, N.H., Aug. 12, 2024 /PRNewswire/ — Bio X Cell, LLC (“BXC” or the “Company”), a leading producer of monoclonal antibodies for pre-clinical in vivo research applications, is pleased to announce the appointment of Christopher Conway as…
SYDNEY, Aug. 12, 2024 /PRNewswire/ — ESY SUNHOME, a premier innovator in renewable energy solutions, has achieved a significant milestone by completing the first successful installation and testing of IEEE 2030.5 cloud-grid integration in South Australia. This groundbreaking advancement…
A Leading Producer of Monoclonal Antibodies LEBANON, N.H., Aug. 12, 2024 /PRNewswire/ — Bio X Cell, LLC (“BXC” or the “Company”), a leading producer of monoclonal antibodies for pre-clinical in vivo research applications, is pleased to announce the appointment of Christopher Conway as…
SUZHOU, China, Aug. 12, 2024 /PRNewswire/ — On August 6, 2024, the msRDN System (SyMapCath I®/ SYMPIONEER S1®), developed by Suzhou/China-based SyMap Medical Ltd. (SyMap Medical), was approved by the National Medical Products Administration (NMPA) of China and granted a Class III Medical…
SHANGHAI, NANJING, China and SAN JOSE, Calif., Aug. 12, 2024 /PRNewswire/ — IASO Biotherapeutics (“IASO Bio”), a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing innovative cell therapy and antibody products, today announced that the…